Table_1_SNP rs4937333 in the miRNA-5003-Binding Site of the ETS1 3′-UTR Decreases ETS1 Expression.DOC by Ruixian Zhang (6167666)

ETs decrease PHD2 expression and promoter activity. by Francesca Spinella (247034)

Predictions of random forests (RF), gradient boosting machines (GBM), and neural networks (NN) trained on 12 covariates chosen using subjective feature selection. by Dennis Ochola (11626912)

Predictions of random forests (RF), gradient boosting machines (GBM), and neural networks (NN) trained on 17 covariates selected after recursive feature selection. by Dennis Ochola (11626912)

Damsin (D) and ambrosin (A) treatment decreases the CSC population. by Wendy Soria Sotillo (4408105)

Restricting cell size decreases [Ca²⁺]_i frequency. by Charles Godbout (540424)

Gfap typically increases with disease progression but decreases in some models in advanced stages of degeneration. by Claire Hippert (171005)

“…<b>E</b>. <i>Pde6b</i>^{<i>rd1/rd1</i>} animals showed a bimodal pattern of Gfap synthesis, with staining being particularly strong at the mid stage, but decreasing thereafter (i-vi). …”

NOX1 activation by ET-1 decreased CD38 in the plasma membrane measured by biotinylated trapping. by Ming Xu (151206)

Affinity analysis results (with a confidence level above 50%). by Marta R. Jabłońska (8491404)

The distributions of the end-simulation adolescence-limited proportion when (a) <i>k</i> is increased or decreased by 50%, (b) <i>c</i> is increased or decreased by 50%, (c) <i>γ</i> is increased or decreased by 50%, and (d) Δ<i>e</i> is increased or decreased by 50%, compared against the benchmark distribution <i>F</i>(<b>p</b>₀) for the parameters shown in Table 1. by Jia Ning Leaw (752775)

Transgenic expression of SPDEF in prostate epithelium decreased prostate carcinogenesis. by Xin-Hua Cheng (154368)

Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder by Jessica J. Matchynski-Franks (3170310)

Subjects:

Decrease in the number of prescriptions for antibiotics in percentage, by studies assessing this outcome parameter. by Christin Löffler (3539528)

Primary endpoint analysis, i.e., time to first occurrence of combined event of 50% decrease in eGFR or ESRD. by Rozita Mohd (7411322)

Effect of newborn anoxia on ET_A- and ET_B-receptor protein abundance in the neonatal heart. by Alexandra N. Paradis (693466)

Detailed meta–analyses in untreated hypothyroid patients compared with controls for each HRV parameters: RR intervals, SDNN, RMSSD, pNN50, TP, LF, HF, LF/HF. by Valentin Brusseau (12769704)

miR-17-92 expression correlates with ETS transcription factors Spi-1 and Fli-1 decrease during 745A#44 cells differentiation. by Samer Kayali (133888)

Expression of SPDEF in prostate adenocarcinoma cells decreased prostate carcinogenesis in orthotopic model. by Xin-Hua Cheng (154368)

Drugs which cluster on the 'anxiolytic' group decrease 5-HT turnover in the brain. by Caio Maximino (100467)

“…<p>(A) Turnover rates, as measured by 5-HIAA:5-HT ratios, normalized to the values of vehicle-treated animals, for the following drugs: fluoxetine (FLX; chronic treatment with 10 mg/kg); chlordiazepoxide (CDZ; 0.02 mg/kg); clonazepam (CLZ; 0.05 mg/kg); diazepam (DZP; 1.25 mg/kg); buspirone (BUS; 50 mg/kg); ethanol (EtOH, 2.5%); dizocilpine (MK; 0.005 mg/kg); verapamil (VER; 5 mg/kg); WAY 100,635 (WAY; 0.03 mg/kg); and SB 224,289 (SB; 2.5 mg/kg). …”

Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”